NCT06617819

Brief Summary

Exploring differences in knee function after surgery with different types of prostheses(Cruciate ligament retaining(CR) VS. posterior stabilizing(PS))

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Sep 2024Dec 2027

First Submitted

Initial submission to the registry

September 22, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

September 30, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Expected
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

1.3 years

First QC Date

September 22, 2024

Last Update Submit

September 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee Society Score, KSS

    Use of Knee Society Score scales for assessment. Including pain, mobility, stability, the patient\'s ability to walk, up and down the stairs, etc. on the assessment, 85-100 is excellent, 70-84 is good, 60-69 is pass, less than 60 is poor

    6 weeks, 3 months, 6 months, 12 months, 24 months after surgery

Secondary Outcomes (4)

  • WOMAC

    Preoperative, 6 weeks, 3 months, 6 months, 12 months, 24 months after surgery

  • Stride length

    Preoperative, 6 weeks, 3 months, 6 months, 12 months, 24 months after surgery

  • Stride frequency

    Preoperative, 6 weeks, 3 months, 6 months, 12 months, 24 months after surgery

  • Percentage of stance phase

    Preoperative, 6 weeks, 3 months, 6 months, 12 months, 24 months after surgery

Study Arms (2)

experimental group

EXPERIMENTAL

CR prosthesis for the left knee

Device: CR prosthesis

control group

ACTIVE COMPARATOR

PS prosthesis for the left knee

Device: PS prosthesis

Interventions

For patients undergoing simultaneous bilateral knee arthroplasty, different prostheses (CR vs. PS) were randomized to the left or right knee.

experimental group

For patients undergoing simultaneous bilateral knee arthroplasty, different prostheses (CR vs. PS) were randomized to the left or right knee.

control group

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 45-80 years, any gender, BMI \< 35 kg/m2
  • Initial diagnosis of bilateral knee OA (Kellgren-Lawrence classification grades 3 or 4). Patients who are to undergo simultaneous primary bilateral knee arthroplasty
  • Inversion deformity ≤ 15°
  • Posterior cruciate ligament integrity

You may not qualify if:

  • History of knee surgery (ligament, osteotomy, etc.)
  • knee flexion\<90°.
  • flexion contracture of one knee \> 10°
  • Comorbidity with other diseases, such as peripheral neuropathy, malignant tumors, rheumatism, etc.
  • Posterior cruciate ligament injury
  • Those assessed to be intolerant of surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

Nanjing, Jiangsu, 210008, China

Location

Study Officials

  • Zhihong Xu, Doctor

    Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhihong Xu, Doctor

CONTACT

Fei Yu, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 22, 2024

First Posted

October 1, 2024

Study Start

September 30, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2027

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

IPD will be available by consulting the principal investigator

Locations